Needle-Free allergy rescue: nasal spray could replace EpiPen
NCT ID NCT07228325
First seen Nov 17, 2025 · Last updated May 12, 2026 · Updated 21 times
Summary
This study tests a new nasal powder form of epinephrine (FMXIN002) against the standard EpiPen injection in 50 healthy adults with allergies. Researchers will measure how quickly and effectively the body absorbs the medicine and how it affects vital signs like blood pressure and heart rate. The goal is to see if the nasal spray is a safe, needle-free option for treating severe allergic reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pharma Medica Research Inc
Mississauga, Canada
Conditions
Explore the condition pages connected to this study.